The UK’s Medicines and Healthcare Products Regulatory Agency’s (MHRA) this week announced major changes to its website meant to incorporate it more thoroughly into the UK government's main website.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Tuesday issued guidance for drugmakers on how to comply with pharmacovigilance requirements in the event the UK leaves the EU ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved serplulimab (Hetronifly, Henlius) to treat adults with extensive-stage small cell lung cancer (ES-SCLC). Serplulimab is the ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield, Aventis Pharma Limited) as the UK’s first immunotherapy for type 1 diabetes (T1D). The drug is licensed ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...